Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
4th August to 4th September 1992
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1992
Report date:
1992

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
EU Method B.6 (Skin Sensitisation)
Version / remarks:
1984
Deviations:
no
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Version / remarks:
1981
Deviations:
no
GLP compliance:
yes
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
The study was conducted well before the LLNA became the recommended standard in vivo method for evaluating the skin sensititsation potential.

Test material

Constituent 1
Chemical structure
Reference substance name:
2,3,4,4'-tetrakis(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonato)benzophenone
EC Number:
424-190-3
EC Name:
2,3,4,4'-tetrakis(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonato)benzophenone
Cas Number:
105641-66-5
Molecular formula:
C53H26N8O17S4
IUPAC Name:
2,3-bis({[5-oxo-6-(λ⁵-diazynylidene)-5,6-dihydronaphthalen-1-yl]sulfonyl}oxy)-6-[4-({[5-oxo-6-(λ⁵-diazynylidene)-5,6-dihydronaphthalen-1-yl]sulfonyl}oxy)benzoyl]phenyl 5-oxo-6-(λ⁵-diazynylidene)-5,6-dihydronaphthalene-1-sulfonate
Test material form:
solid

In vivo test system

Test animals

Species:
guinea pig
Strain:
other: Pirbright-White guinea pig
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Hoechst AG, Kastengrund, SPF breeding colony
- Weight at study initiation: 234-306 g
- Housing: MAkrolon type 4 cage, groups of 5
- Diet: ad libitum Altromin 3112
- Water: ad libitum tap water
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+/- 3
- Humidity (%): 55 +/- 20
- Photoperiod (hrs dark / hrs light): 12/12

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal
Vehicle:
paraffin oil
Concentration / amount:
1 %
Day(s)/duration:
Day 1
Adequacy of induction:
highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
Route:
epicutaneous, occlusive
Vehicle:
petrolatum
Concentration / amount:
0.5 g test substance, 25 % in petrolatum
Day(s)/duration:
Day 8
Adequacy of induction:
other: non-irritant substance
Challenge
No.:
#1
Route:
epicutaneous, occlusive
Vehicle:
petrolatum
Concentration / amount:
0.5 g test substance, 25 % in petrolatum
Day(s)/duration:
Day 22
No. of animals per dose:
Treatment group: 10, Control group: 5, Escort group: 5
Details on study design:
RANGE FINDING TESTS:
The primary non-irritant concentration was determined in a dermal-occlusive test with test substance concentrations of 1, 5 and 25 % in petrolatum. No signs of irritation occurred at the different concentrations.
To determine the tolerance of intradermal injections, each of the following preparations was administered twice by intradermal injection to 3 guinea pigs: 0.2, 1 and 5 % in semi-liquid paraffine. The injections with 1 and 5 % preparations caused very sight to moderate erythema and edema. The injections with the 0.2 % preparation caused very slight to moderate erythema and edema. Based on this test, a 1 % preparation was selected for the intradermal injections in the main test.

MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (intradermal and dermal)
- Exposure period: Day 1 intradermal induction, Day 8 dermal application
- Site: injections: dorsal, dermal applications: same area
- Duration: dermal application: 24 hours under occlusion
- Concentrations: intradermal: 1 %, dermal: 25%

B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day of challenge: 22
- Exposure period: 24 hours
- Site: left flank
- Concentrations: 25 %
- Evaluation (hr after challenge): 24 and 38 hours after removal of dressing
Challenge controls:
25 % test substance in petrolatum
Positive control substance(s):
no

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Group:
positive control
Remarks on result:
not measured/tested
Group:
negative control
Remarks on result:
not measured/tested
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
25 % in petrolatum
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
no indication of skin sensitisation
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
25 % test substance
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
Body weight gain of the animals was not impaired.
Remarks on result:
no indication of skin sensitisation

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
Under the given experimental conditions, the test material induced no reactions. Therefore, the test item is considered not to cause skin sensitisation.
Executive summary:

The purpose of this GPMT assay was to identify the contact allergenic potential of the test item. The test was performed according to OECD Guideline No 406. Intradermal induction was performed using 1 % test item in semi-liquid paraffine. Dermal induction and challenge treatment were carried out with 25 % test substance in petrolatum. Based on the results of this study there is no evidence for a sensitizing property of the test item.